Classics in Neuroimaging: Imaging the Cholinergic System with Positron Emission Tomography
- 23 April 2021
- journal article
- editorial
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 12 (9) , 1472-1479
Abstract
Since the earliest days of nuclear medicine, there has been interest in using PET and SPECT imaging to interrogate and quantify the cholinergic system. In this Viewpoint we highlight key milestones in the development of cholinergic imaging agents, including identification of radiopharmaceuticals targeting the receptors, transporters, and enzymes of the cholinergic synapse, as well as fundamental developments in the radiopharmaceutical sciences (e.g., cyclotron targetry, radiochemistry) that have enabled translation of the most promising agents into clinical use. We also provide an overview of the current state-of-the-art in cholinergic PET imaging, with an emphasis on radiotracers that are in human studies at PET centers around the world.Keywords
Funding Information
- University of Michigan (Michigan Research and Discovery Scholars (MRADS))
This publication has 6 references indexed in Scilit:
- First-in-Human Assessment of 11C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET RadiotracerJournal of Nuclear Medicine, 2020
- First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (−)-[18F]FlubatineNeuroImage, 2015
- Human Brain Imaging of α7 nAChR with [18F]ASEM: a New PET Radiotracer for Neuropsychiatry and Determination of Drug OccupancyMolecular Imaging and Biology, 2014
- In Vivo Imaging of Human Cholinergic Nerve Terminals with (–)-5-18F-Fluoroethoxybenzovesamicol: Biodistribution, Dosimetry, and Tracer Kinetic AnalysesJournal of Nuclear Medicine, 2014
- In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer’s diseaseNeurology, 1999
- External Imaging of Cerebral Muscarinic Acetylcholine ReceptorsScience, 1984